CytoSorbents Receives $5M In Non-Dilutive Debt Financing From Bridge Bank And Extends Loan Agreement
PRINCETON, N.J., Dec. 29, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery